Build a Cascade Screening Outreach Platform for Genetics Clinics

1. 1

   Understand the clinical problem precisely

   Cascade screening means testing the relatives of a person found to carry a serious hereditary variant, radiating outward from each new positive. Research consistently shows patient-mediated notification underperforms and direct, health-system-led contact reaches more relatives, but direct contact requires the patient's consent under HIPAA. The platform's job is making the consented version operationally easy.

2. 2

   Design consent as the foundation, not a checkbox

   The proband (the first diagnosed patient) explicitly authorizes which relatives may be contacted and what may be shared. Without that authorization, contacting relatives with the patient's health information can violate HIPAA and state privacy laws. Granular, documented, revocable consent per relative is the load-bearing wall of the entire product.

3. 3

   Build the counselor's command center

   A family pedigree view with outreach status per relative: consented, contacted, responded, counseled, tested, result recorded. Automated respectful follow-ups, template letters reviewed by the clinic, and scheduling links replace the sticky notes and spreadsheets counselors use today.

4. 4

   Operate inside the compliance perimeter

   You are a HIPAA business associate: signed BAAs with every clinic, encryption in transit and at rest, access controls, audit logs, and breach procedures. Relatives who respond become their own consented individuals, not shadow records. Budget for a healthcare attorney and a security assessment before the first pilot; in this category, compliance is the product.

5. 5

   Stay a coordination tool, not a medical actor

   The platform never interprets results, never advises testing, and never contacts anyone outside the consented workflow. Clinicians counsel; labs test; the software coordinates and documents. Keeping that boundary explicit is both the regulatory posture and the sales pitch to cautious clinics.

6. 6

   Pilot with one hereditary program and publish the delta

   Hereditary cancer and familial cardiac programs measure cascade uptake and mostly hate their numbers. A pilot showing more relatives reached and tested, with clean documentation, is the evidence that sells the next ten programs and interests the payers who save money on every early detection.

Do not take our word for the money. Put your own numbers in and see what this idea has to earn before it works. Free, instant, no account needed.

Best for: A health-tech builder who can work closely with genetic counselors and take compliance seriously

Not for: Builders who want to move fast around consent, skip the clinical partnership, or ship first and comply later. In this category the careful path is the only path.